ICGEB Workshop – Transcription Factors in Cancer Therapy concluded at ICGEB Cape Town

news on 24 Oct , 2018
Dr. Giuseppina Carbone and Prof. Carlo Catapano lectured at the ICGEB workshop held in Cape Town (South Africa) on the role of ETS and STAT3 transcription factors in cancer therapy. L-R: Jacquelene Friedenthal (Embassy of Switzerland), Dr. Carbone, Mr. Muofhe,  Prof. Catapano, Dr. Zerbini and Dr. Banks http://www.icgeb.org/news_English/items/icgeb-workshop-transcription-factors-in-cancer-th...
More

New publication by Dr. Francesco Bertoni’s lab

news on 23 Oct , 2018
The research team led by Dr. Francesco Bertoni has discovered a regulatory link between BRD4, a key Bromodomain and Extra Terminal (BET) domain protein, and microRNAs, a potential magic bullet in cancer. Afua Adjeiwaa Mensah, PhD and Luciano Cascione, PhD (Lymphoma Genomics group, Institute of Oncology Research, Bellinzona), and colleagues provide the first evidence of BET inhibitor modulation ...
More

New paper by Dr. Francesco Bertoni lab

news on 22 Oct , 2018
The research team led by Dr. Francesco Bertoni has discovered the potential role of Bromodomain and Extra Terminal domain (BET) inhibitor birabresib (MK-8628/OTX015) in treating mantle cell lymphoma (MCL) patients, which are still in need of therapeutic improvement. Innovative results have been published in ESMO Open journal. BET proteins act as transcriptional regulators of key signaling pathw...
More